目次
Contents
1. Executive Summary
2. Global Pacemaker Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Pacemaker Market Analysis
10.1. Porter Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Pacemaker Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. Global Pacemaker Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Type: Market Share (2020-2031F)
12.2.1. MRI Compatible Pacemakers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Conventional Pacemakers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Heart Block, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Congestive Heart Failure, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.4. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By Product: Market Share (2020-2031F)
12.4.1. Single Chamber, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Dual Chamber, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Biventricular Chamber, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.5. By Implant Ability: Market Share (2020-2031F)
12.5.1. Implantable Pacemaker, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.5.2. External Pacemaker, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.6. By End User: Market Share (2020-2031F)
12.6.1. Hospitals & Cardiac Centers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.6.2. Ambulatory Surgical Centers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.6.3. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. Company Profile
13.1. Abbott LaboratoriesCompany Overview
13.1.1. Company Total Revenue (Financials)
13.1.2. Market Potential
13.1.3. Global Presence
13.1.4. Key Performance Indicators
13.1.5. SWOT Analysis
13.1.6. Product Launch
13.2. Medtronic
13.3. Zoll Medical Corporation
13.4. MicroPort Scientific Corporation
13.5. MEDICO Spa
13.6. Boston Scientific Corporation
13.7. Pacetronix
13.8. Oscor Inc.
13.9. Osypka Medical GmbH
13.10. Cook Medical
13.11. Other Prominent Players
Consultant Recommendation
The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
